Viana Antonio J - May 30, 2024 Form 4 Insider Report for Arteris, Inc. (AIP)

Role
Director
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Antonio J. Viana
Stock symbol
AIP
Transactions as of
May 30, 2024
Transactions value $
-$211,435
Form type
4
Date filed
6/10/2024, 04:16 PM
Previous filing
Apr 9, 2024
Next filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIP Common Stock Gift $0 -2.78K -5.44% $0.00 48.3K May 30, 2024 Direct F1
transaction AIP Common Stock Gift $0 +2.78K +1.4% $0.00 202K May 30, 2024 Viana Family Trust F1
transaction AIP Common Stock Gift $0 -29K -60.08% $0.00 19.3K Jun 6, 2024 Direct F1, F2
transaction AIP Common Stock Gift $0 +29K +14.4% $0.00 231K Jun 6, 2024 Viana Family Trust F1
transaction AIP Common Stock Sale -$211K -26.9K -11.68% $7.85 204K Jun 7, 2024 Viana Family Trust F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares were transferred to the Viana Family Trust for which the reporting person is the trustee.
F2 Includes 19,287 restricted stock units.
F3 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 5, 2022.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.69 to $8.08 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.